Silgan Holdings Inc.: 52-Week High Recently Eclipsed (SLGN)

September 12, 2022 10:18:47

Silgan Holdings Inc. (NYSE:SLGN) traded at a new 52-week high today of $48.61. So far today approximately 64,000 shares have been exchanged, as compared to an average 30-day volume of 512,000 shares.

Silgan Holdings Inc. (NYSE:SLGN) defies analysts with a current price ($48.48) 4.0% above its average consensus price target of $46.51.

Silgan Holdings Inc. share prices have moved between a 52-week high of $48.61 and a 52-week low of $37.10 and are now trading 31% above that low price at $48.48 per share.

Silgan Holdings Inc manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan is looking for more merger and acquisition opportunities in the European metal packaging market and in plastic packaging. Silgan’s other business segments include plastic containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit

About IBN (InvestorBrandNetwork)

IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.

For more information on IBN, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: